BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37929660)

  • 21. LncRNA LINC00472 regulates cell stiffness and inhibits the migration and invasion of lung adenocarcinoma by binding to YBX1.
    Deng X; Xiong W; Jiang X; Zhang S; Li Z; Zhou Y; Xiang B; Zhou M; Li X; Li G; Zeng Z; Gong Z
    Cell Death Dis; 2020 Nov; 11(11):945. PubMed ID: 33144579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LINC01857 as an oncogene regulates CREB1 activation by interacting with CREBBP in breast cancer.
    Xiong Y; Gu Y; Wang F; Li L; Zhu M; Wang N; Mi H; Qiu X
    J Cell Physiol; 2019 Aug; 234(8):14031-14039. PubMed ID: 30628071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective sorting and secretion of hY4 RNA fragments into extracellular vesicles mediated by methylated YBX1 to promote lung cancer progression.
    Li C; Wang W; Sun Y; Ni Y; Qin F; Li X; Wang T; Guo M; Sun G
    J Exp Clin Cancer Res; 2022 Apr; 41(1):136. PubMed ID: 35410432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways.
    Zhang Z; Yu W; Zheng M; Liao X; Wang J; Yang D; Lu W; Wang L; Zhang S; Liu H; Zhou XZ; Lu KP
    Mol Carcinog; 2019 Aug; 58(8):1450-1464. PubMed ID: 31026381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of microRNA-370 in esophageal squamous-cell carcinoma is associated with cancer progression and promotes cancer cell proliferation via upregulating PIN1.
    Chen M; Xia Y; Tan Y; Jiang G; Jin H; Chen Y
    Gene; 2018 Jun; 661():68-77. PubMed ID: 29605603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.
    Hu N; Ji H
    Bioengineered; 2021 Dec; 12(1):4081-4091. PubMed ID: 34288797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer.
    Liu Y; Zhao J; Zhang W; Gan J; Hu C; Huang G; Zhang Y
    Sci Rep; 2015 May; 5():10159. PubMed ID: 25959498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
    Yan K; Tian J; Shi W; Xia H; Zhu Y
    Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pin1 promotes pancreatic cancer progression and metastasis by activation of NF-κB-IL-18 feedback loop.
    Sun Q; Fan G; Zhuo Q; Dai W; Ye Z; Ji S; Xu W; Liu W; Hu Q; Zhang Z; Liu M; Yu X; Xu X; Qin Y
    Cell Prolif; 2020 May; 53(5):e12816. PubMed ID: 32347623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro.
    Lim JP; Shyamasundar S; Gunaratne J; Scully OJ; Matsumoto K; Bay BH
    BMC Cancer; 2017 Mar; 17(1):201. PubMed ID: 28302118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-585-5p impedes gastric cancer proliferation and metastasis by orchestrating the interactions among CREB1, MAPK1 and MITF.
    Wang Y; Li M; Zeng J; Yang Y; Li Z; Hu S; Yang F; Wang N; Wang W; Tie J
    Front Immunol; 2022; 13():1008195. PubMed ID: 36268034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis.
    Xie N; Zhang R; Bi Z; Ren W; You K; Hu H; Xu Y; Yao H
    Cell Oncol (Dordr); 2023 Apr; 46(2):375-390. PubMed ID: 36576700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
    Sun X; Xin S; Zhang Y; Jin L; Liu X; Zhang J; Mei W; Zhang B; Ma W; Ye L
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35904175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA DQ786243 interacts with miR-506 and promotes progression of ovarian cancer through targeting cAMP responsive element binding protein 1.
    Yan H; Silva MA; Li H; Zhu L; Li P; Li X; Wang X; Gao J; Wang P; Zhang Z
    J Cell Biochem; 2018 Dec; 119(12):9764-9780. PubMed ID: 30105876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling.
    Li H; Wang Y
    Med Sci Monit; 2019 Jan; 25():656-665. PubMed ID: 30670679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA HOXA10-AS functions as an oncogene by binding miR-6509-5p to upregulate Y-box binding protein 1 in gastric cancer.
    Li S; Lu C; Li X; Li F; Zhao Y; Xu M; Jia H; Yuan S
    Bioengineered; 2022 May; 13(5):11373-11387. PubMed ID: 35521747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1α in clear cell renal cell carcinoma.
    Zhao P; Deng Y; Wu Y; Guo Q; Zhou L; Yang X; Wang C
    FASEB J; 2021 Feb; 35(2):e21160. PubMed ID: 33150667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
    Hussain SA; Venkatesh T
    Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma.
    Wang Y; Feng YC; Gan Y; Teng L; Wang L; La T; Wang P; Gu Y; Yan L; Li N; Zhang L; Wang L; Thorne RF; Zhang XD; Cao H; Shao FM
    J Exp Clin Cancer Res; 2022 Aug; 41(1):260. PubMed ID: 36028903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.